{"first_name":"Carl","last_name":"Eibl","permalink":"carl-eibl","crunchbase_url":"http://www.crunchbase.com/person/carl-eibl","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Tue Dec 02 04:37:49 UTC 2008","updated_at":"Thu Jun 04 13:51:22 UTC 2009","overview":"<p>Carl Eibl is a Managing Director at Enterprise Partners. In addition to serving as an investment partner, Carl is also responsible for managing the firm. At Enterprise, Carl leads investments in Internet 2.0, web and software based businesses, as well as restructurings and business buyouts and combinations. Carl serves on the boards of numerous Enterprise portfolio companies - BMS, DragonWave (TSX/AIM: DWI), Enviance, IdenTrust, Muze, NEXX, NP Photonics, Pivotal, ReliOn,  SpecificMEDIA, The Retail Equation, TradeBeam, and vMix. He also serves on the boards of The Burnham Institute for Medical Research and of CONNECT.</p>\n\n<p>Prior to joining Enterprise in 2003, Carl was the CEO of several high profile technology and life science companies in San Diego. As CEO of publicly-held Maxwell Technologies (MXWL), Carl led the recreation of Maxwell from an engineering and physics service organization for the U.S. military to a high-tech business that develops, manufactures and commercializes energy storage devices called ultracapacitors in the industrial, energy and transportation markets and single board computers and components in the satellite and space market. Before joining Maxwell, Carl served as President of Stratagene Corporation (STGN), then a privately-held biotechnology company selling DNA, RNA, biologicals and laboratory instruments in the pharmaceutical and university biotech research markets.   Stratagene was acquired by Agilent Corporation in 2007 for $250 million.  Carl also served as CEO for Mycogen Corporation a publicly-held agricultural, biotechnology company, which was sold to The Dow Chemical Company at the end of 1998 for $1.1 billion.</p>","image":{"available_sizes":[[[150,150],"assets/images/resized/0004/6698/46698v1-max-150x150.png"],[[201,201],"assets/images/resized/0004/6698/46698v1-max-250x250.png"],[[201,201],"assets/images/resized/0004/6698/46698v1-max-450x450.png"]],"attribution":""},"degrees":[{"degree_type":"J.D. ","subject":"","institution":"Boston University School of Law","graduated_year":null,"graduated_month":null,"graduated_day":null}],"relationships":[{"is_past":false,"title":"Managing Director","firm":{"name":"Enterprise Partners","permalink":"enterprise-partners","type_of_entity":"financial_org","image":{"available_sizes":[[[150,50],"assets/images/resized/0003/0632/30632v1-max-150x150.png"],[[225,75],"assets/images/resized/0003/0632/30632v1-max-250x250.png"],[[225,75],"assets/images/resized/0003/0632/30632v1-max-450x450.png"]],"attribution":null}}},{"is_past":false,"title":"Director","firm":{"name":"Nexx Systems","permalink":"nexx-systems","type_of_entity":"company","image":{"available_sizes":[[[150,69],"assets/images/resized/0006/7338/67338v1-max-150x150.jpg"],[[202,94],"assets/images/resized/0006/7338/67338v1-max-250x250.jpg"],[[202,94],"assets/images/resized/0006/7338/67338v1-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}